Group 1 - The core viewpoint of the news is that Lifan Pharmaceutical's stock has increased by 5.37%, reaching a price of 28.46 CNY per share, with a total market capitalization of 5.413 billion CNY as of the report date [1] - Lifan Pharmaceutical, established on July 16, 2002, and listed on December 15, 2020, is primarily engaged in the research, production, and sales of pharmaceutical formulations and raw materials, with 97.50% of its revenue coming from pharmaceutical products [1] - The company has a trading volume of 91.038 million CNY and a turnover rate of 2.38% [1] Group 2 - In the context of major shareholders, Invesco Great Wall Fund's healthcare mixed fund has entered the top ten circulating shareholders of Lifan Pharmaceutical, holding 910,100 shares, which is 0.66% of the circulating shares [2] - The Invesco Great Wall Healthcare Mixed A Fund (011876) has achieved a year-to-date return of 28.64% and a one-year return of 24.58%, ranking 3331 out of 8154 and 3709 out of 8046 in its category, respectively [2] - The fund was established on August 18, 2021, and has a current scale of 368 million CNY, with an estimated floating profit of approximately 1.3196 million CNY from its investment in Lifan Pharmaceutical [2]

Core Insights - Cube Pharmaceuticals (003020.SZ) reported its Q3 2025 results on October 30, 2025, highlighting a total of 39.4014 million A-shares held by three institutional investors, representing 20.72% of the company's total share capital [1] Institutional Holdings - The institutional investors include Hefei Cube Investment Group Co., Ltd., China Merchants Fund Management Co., Ltd. - Social Security Fund 2108 Portfolio, and China Minsheng Bank Co., Ltd. - Invesco Great Wall Medical Health Mixed Securities Investment Fund [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 0.06 percentage points [1] Public Fund Activity - One new public fund disclosed its holdings in Cube Pharmaceuticals this quarter, specifically Invesco Great Wall Medical Health Mixed Class A [1] - A total of 60 public funds were not disclosed in this quarter compared to the previous one, including Hai Fu Tong Growth Value Mixed A, CITIC Construction Investment Rotation Mixed A, and others [1] Social Security Fund - One new social security fund disclosed its holdings in Cube Pharmaceuticals, which is the China Merchants Fund Management Co., Ltd. - Social Security Fund 2108 Portfolio [1]